Journey Medical Corp (DERM) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Journey Medical reported revenue of $61.9M, up 10.2% from $56.1M the year before. Net income was -$11.4M (a -18.5% net margin), or -$0.47 per diluted share. Gross margin was 66.2% and operating margin was -13.2%. Operating activities generated -$12.4M of cash, leaving -$27.4M of free cash flow. At fiscal year end, Journey Medical held $94.6M in total assets against $62.7M in total liabilities, including $24.1M of cash and equivalents.
Open the full interactive Journey Medical financials → Quarterly statements, key ratios, valuation history and price charts.
Journey Medical Key Stats
| Share Price | $5.68 |
|---|---|
| Market Cap | $156.2M |
| Revenue YoY Growth | +10.2% |
| 52-Week Range | $4.39 – $9.26 |
| Shares Outstanding | 27.5 million (basic, 2026 Q2) |
Journey Medical Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $63.1M | $73.7M | $79.2M | $56.1M | $61.9M |
| Cost of Goods Sold | $98.0M | $101.2M | $81.3M | $69.8M | $70.0M |
| Gross Profit | $31.1M | $42.9M | $52.5M | $35.3M | $40.9M |
| Operating Income | -$34.9M | -$27.5M | -$2.1M | -$13.7M | -$8.2M |
| Pre-Tax Income | -$42.4M | -$29.6M | -$3.6M | -$14.6M | -$11.4M |
| Income Tax | $1.6M | $63,000 | $221,000 | $61,000 | $60,000 |
| Net Income | -$44.0M | -$29.6M | -$3.9M | -$14.7M | -$11.4M |
| Diluted EPS | -$4.32 | -$1.69 | -$0.21 | -$0.72 | -$0.47 |
Journey Medical Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $17.6M | $16.1M | $16.0M | $18.5M |
| Net Income | -$2.3M | -$1.2M | -$2.2M | -$312,000 |
| Diluted EPS | -$0.09 | -$0.05 | -$0.08 | -$0.01 |
Journey Medical Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $49.1M | $32.0M | $27.4M | $20.3M | $24.1M |
| Current Assets | $84.5M | $77.7M | $56.5M | $48.2M | $66.9M |
| Total Assets | $97.3M | $105.2M | $76.8M | $80.2M | $94.6M |
| Current Liabilities | $51.6M | $66.8M | $41.9M | $35.2M | $37.4M |
| Total Long-Term Debt | — | $27.8M | $14.6M | $24.9M | $25.3M |
| Total Liabilities | $55.2M | $88.2M | $56.5M | $60.2M | $62.7M |
| Shareholders' Equity | $42.0M | $17.0M | $20.4M | $20.1M | $31.9M |
Journey Medical Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$2.2M | -$13.5M | $5.2M | -$9.1M | -$12.4M |
| Cash From Investing | -$10.0M | -$20.0M | -$5.0M | -$15.0M | — |
| Cash From Financing | $53.0M | $16.5M | -$4.8M | $17.0M | $16.2M |
| Free Cash Flow | — | -$33.5M | $240,000 | -$24.1M | -$27.4M |
Figures from Journey Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Journey Medical financials page for every line item.
Journey Medical Company Profile
| Ticker | DERM |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Scottsdale, Arizona |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0001867066 |
Frequently Asked Questions
What was Journey Medical's revenue in fiscal 2025?
Journey Medical (DERM) reported revenue of $61.9M for fiscal 2025.
What is Journey Medical's annual revenue history?
Journey Medical's annual revenue by fiscal year: 2021: $63.1M; 2022: $73.7M; 2023: $79.2M; 2024: $56.1M; 2025: $61.9M.
What was Journey Medical's net income in fiscal 2025?
Journey Medical reported net income of -$11.4M for fiscal 2025.
What was Journey Medical's earnings per share (EPS) in fiscal 2025?
Journey Medical's diluted EPS was -$0.47 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Journey Medical generate in fiscal 2025?
Journey Medical generated -$27.4M of free cash flow in fiscal 2025.
What was Journey Medical's revenue last quarter?
In its most recent reported quarter (2026 Q2), Journey Medical reported revenue of $18.5M.
How much debt does Journey Medical have?
Journey Medical reported $25.3M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Journey Medical are outstanding?
Journey Medical reported a weighted average of 27.5 million basic shares outstanding in 2026 Q2.
What is Journey Medical's market cap?
Based on its latest closing price, Journey Medical (DERM) has a market capitalization of about $156.2M.
When does Journey Medical's fiscal year end?
Journey Medical's fiscal year end, as registered with the SEC, is December 31.
Where is Journey Medical headquartered?
Journey Medical lists its business address in Scottsdale, Arizona in its SEC filings.